Getting the best outcomes from epilepsy surgery.

Neurosurgery is an underutilized treatment that can potentially cure drug-refractory epilepsy. Careful, multidisciplinary presurgical evaluation is vital for selecting patients and to ensure optimal outcomes. Advances in neuroimaging have improved diagnosis and guided surgical intervention. Invasive electroencephalography allows the evaluation of complex patients who would otherwise not be candidates for neurosurgery. We review the current state of the assessment and selection of patients and consider established and novel surgical procedures and associated outcome data. We aim to dispel myths that may inhibit physicians from referring and patients from considering neurosurgical intervention for drug-refractory focal epilepsies. Ann Neurol 2018;83:676-690

Visual and Contextual Modeling for the Detection of Repeated Mild Traumatic Brain Injury.

Currently, there is a lack of computational methods for the evaluation of mild traumatic brain injury (mTBI) from magnetic resonance imaging (MRI). Further, the development of automated analyses has been hindered by the subtle nature of mTBI abnormalities, which appear as low contrast MR regions. This paper proposes an approach that is able to detect mTBI lesions by combining both the high-level context and low-level visual information. The contextual model estimates the progression of the disease using subject information, such as the time since injury and the knowledge about the location of mTBI. The visual model utilizes texture features in MRI along with a probabilistic support vector machine to maximize the discrimination in unimodal MR images. These two models are fused to obtain a final estimate of the locations of the mTBI lesion. The models are tested using a novel rodent model of repeated mTBI dataset. The experimental results demonstrate that the fusion of both contextual and visual textural features outperforms other state-of-the-art approaches. Clinically, our approach has the potential to benefit both clinicians by speeding diagnosis and patients by improving clinical care

Development of an image processing pipeline for the study of corticol lesions in multiple sclerosis patients using ultra-high field MRI

Tese de mestrado integrado, Engenharia Biomédica e Biofísica (Biofísica Médica e Fisiologia de Sistemas), Universidade de Lisboa, Faculdade de Ciências, 2019A esclerose múltipla é uma doença crónica e inflamatória do sistema nervoso central de alta prevalência nos dias de hoje. Durante anos, o foco da doença foi a patologia visível na matéria branca. Apesar dos primeiros estudos de patologia cortical em esclerose múltipla apontarem para a década de 60, foi apenas no início do novo século que o córtex passou a ser estudado como parte integral da doença. Desde então, estudos têm vindo a demonstrar que o comprometimento do córtex parece estar relacionado com danos cognitivos e físicos, frequentemente associados à doença. A necessidade de melhor compreender o impacto das lesões corticais no desenvolvimento da doença e na vida diária destes pacientes tem motivado o seu estudo, sendo a Ressonância Magnética (RM), em particular scanners de campo ultra-alto, a melhor ferramenta para as detetar e estudar. A melhoria da razão sinal-ruído e da resolução espacial dos scanners de RM de campo ultra-alto tem permitido o aumento da deteção de lesões corticais. Ainda assim, a sua sensibilidade continua a não ser ideal e a estar fortemente dependente do tipo de lesão cortical, do contraste de RM usado na sua deteção e da existência de ferramentas robustas que permitam a sua deteção de modo automático, mais eficiente e com menor espaço para erro. A falta de marcadores de imagem para a remielinização ou desmielinização parcial, tal como a ausência de diretrizes para a deteção destas lesões com campos de 7 (T)esla parece explicar a dificuldade em distinguir e identificar falsos positivos e as diferenças encontradas nas deteções realizadas por diferentes avaliadores. Uma desvantagem dos scanners de campo ultra-alto é o maior efeito de bias que, caso não seja removido aquando da aquisição de imagens, terá de ser removido na fase de processamento por softwares e algoritmos que não estão originalmente construídos para trabalhar com imagens de maior resolução e cuja prestação não está ainda bem explorada nestas condições. Estes desafios comprometem o potencial dos scanners de RM de campo ultra-alto para o estudo das lesões corticais na esclerose múltipla. Este projeto procura desenvolver uma pipeline semiautomática para o pré-processamento e processamento de imagens de RM de cariz estrutural de doentes com esclerose múltipla obtidas num scanner de campo ultra-alto. A pipeline é criada de modo gradual, recorrendo a análises visuais, ou de outro tipo, para confirmar a qualidade de cada passo antes de avançar para o seguinte, no pressuposto de que a qualidade dos softwares de imagem comercialmente disponíveis será menor ao utilizar imagens de maior resolução. A ocorrência de lesões corticais no córtex sensório-motor (SM1) é igualmente determinada e usada para validar a qualidade da pipeline. Doze doentes com esclerose múltipla na sua forma recidivante-remitente ou secundariamente progressiva e seis controlos foram incluídos neste projeto. Todas as permissões necessárias do comité local de ética, proteção de dados e da Danish Medicines Agency foram previamente obtidas. Os doentes foram estudados num scanner de RM de corpo inteiro da Philips, Achieva 7,0 T, dedicado a investigação. Os participantes foram observados usando quatro tipos distintos de contraste: magnetization prepared rapid acquisition by gradient echo (MPRAGE) a três dimensões (3D) com 0,65-mm de resolução isotrópica, 3D fluid attenuated inversion recovery (FLAIR) com 0,7-mm de resolução isotrópica, 3D T1-weighted (T1w) de resolução 0,85x0,85x1,0 mm3 e 3D T2-weighted Turbo Spin Echo (T2w-TSE) de 0,4-mm de resolução isotrópica. A vertente de pré-processamento da pipeline incluiu uma correção de bias e o co-registo de imagens. Para a correção de bias, o software SPM foi testado utilizando os parâmetros habituais e uma alteração dos parâmetros relativos à smoothness e regularização, como sugerido na literatura. O processo de co-registo seguiu o procedimento utilizado no processamento de imagens de doentes com esclerose múltipla de 3 T no Danish Research Centre for Magnetic Resonance (DRCMR), com alterações posteriormente adicionadas para melhorar a qualidade do alinhamento das imagens de cada indivíduo a 7 T. Após o pré-processamento, uma deteção de lesões corticais, seguida da sua segmentação, foi realizada manualmente utilizando as ferramentas do software FSL. A vertente de processamento da pipeline incluiu uma segmentação do cérebro, um registo das imagens dos doentes e a criação de superfícies corticais. A segmentação foi testada utilizando três diferentes ferramentas: o software SPM, uma toolbox do SPM, CAT, e a ferramenta de segmentação do FSL, FAST. A toolbox do SPM, DARTEL, foi usada no registo de imagens e o software FreeSurfer permitiu a criação de superfícies individuais e de grupo no último passo da pipeline. As máscaras com as lesões criadas após a segmentação manual de lesões seguiram um caminho semelhante de processamento de modo a permitir a sua correta sobreposição no respetivo volume, e, posteriormente, superfície, e a possibilidade de fazer análises individuais ou de grupo. Os resultados obtidos mostraram que os softwares para processamento de imagens de RM disponíveis apresentam, em geral, uma boa prestação e fornecem resultados de confiança. Ainda assim, a sua prestação pode ser otimizada incluindo procedimentos adicionais em cada passo ou por alteração das configurações originais dos softwares. A diminuição do parâmetro de largura à meia altura com um aumento do parâmetro de regularização na correção de bias com o SPM permitiu a criação de campos de bias mais fieis às imagens originais, consequentemente melhorando a sua correção e a diferenciação da matéria branca e matéria cinzenta nas imagens resultantes. A criação adicional de máscaras contendo apenas o cérebro e a utilização exclusiva de transformações de corpo rígido no co-registo de imagens permitiu a utilização de vários contrastes na tarefa de deteção de lesões, sem interferir com a sua localização ou morfologia. Na segmentação, a toolbox do SPM, CAT, mostrou melhorias na capacidade de separar as diferentes classes de tecidos com maior confiança e qualidade, particularmente nas regiões de contacto entre a matéria branca e cinzenta. Consequentemente, a qualidade do alinhamento das imagens dos diferentes doentes e a posterior criação de uma imagem média a partir de imagens individuais foi melhorada. O sucesso da pipeline permitiu a sobreposição das lesões corticais manualmente segmentadas nas superfícies individuais e/ou comuns criadas, onde foi descoberto que a maioria das lesões ocorreu no hemisfério direito, com sobreposições de lesões respetivas a diferentes doentes a ocorrer maioritariamente nos sulcos corticais, comparativamente aos giros. Porém, a segmentação de lesões demonstrou ser dispendiosa, dependente do avaliador e altamente influenciada por fatores inerentes ao avaliador, tal como o cansaço, nível de concentração ou de aborrecimento, e fatores externos, no qual se destacam a luminosidade do computador ou a luminosidade da sala onde a deteção foi feita. A feature do FreeSurfer para imagens de maior resolução não se mostrou fiável no tratamento dos dados de resolução isotrópica de 0,5-mm deste projeto, uma possível razão pela qual ainda se encontra em desenvolvimento. Apesar dos bons resultados obtidos, investigação adicional será necessária para melhor compreender a prestação destes e de outros softwares para imagem médica no processamento de imagens de RM de maior resolução, tal como a melhor maneira de tirar partido dos mesmos em estudos clínicos a 7 T. A extensão da pipeline a outros doentes com esclerose múltipla irá aumentar a amostra em estudo e permitir um estudo mais extensivo da patologia cortical e a compreensão do impacto de uma ou mais lesões localizadas na região SM1 na conectividade e integridade funcional da região cortical afetada.The importance of grey matter pathology to the understanding of multiple sclerosis has been acknowledged. However, the sensitivity to cortical lesions is limited when using conventional magnetic resonance imaging (MRI) systems. Ultra-high field (UHF) MRI systems have improved detection sensitivity but impose the additional challenge of a higher effect of bias to account for. Currently, image processing tools are not designed for higher resolution data and the performance of common software packages under these conditions has not been properly explored. These challenges have impaired the potential of UHF-MRI to study cortical lesions in multiple sclerosis. This project aims at developing a semi-automated pipeline for the pre-processing and processing of structural UHF-MRI data of multiple sclerosis patients. The pipeline is built in a step-by-step fashion, making use of visual assessments and other analyses to confirm the quality of each step before advancing to the next, under the assumption that the performance of common imaging software packages will be poorer when using higher resolution data. The occurrence of cortical lesions within the primary sensory-motor cortex (SM1) is also determined and used to validate the quality of the pipeline. Twelve patients with relapsing-remitting multiple sclerosis or secondary progressive multiple sclerosis and six healthy age-matched controls were included in this project. All relevant permissions from the local ethics committee and data protection had been obtained beforehand. All participants were studied with whole-brain ultra-high field MRI at 7 Tesla (T), using a research-only 7 T Achieva MR system. The participants were scanned using four different MRI modalities, namely 3-dimensional (3D) magnetization prepared rapid acquisition by gradient echo (MPRAGE) at 0.65-mm isotropic resolution, 3D fluid attenuated inversion recovery (FLAIR) at 0.7-mm isotropic resolution, 3D T1-weighted (T1w) of 0.85x0.85x1.0 mm3 reconstructed resolution and 3D T2-weighted Turbo Spin Echo (T2w-TSE) at 0.4-mm isotropic reconstructed resolution. The pre-processing pipeline included a bias correction and a coregistration step. For the bias correction, SPM was tested using its default parameters and an alternative configuration that altered the smoothness and regularization parameters. The coregistration followed an approach used in the processing of multiple sclerosis data at 3 T, with changes added to improve the quality of the within-subject alignment at 7 T. After the data pre-processing, manual detection and segmentation of cortical lesions was performed using FSLeyes. The processing pipeline included brain segmentation, subject registration and cortical surface creation. Brain segmentation was tested with SPM, with SPM’s toolbox, CAT, and with FSL’s segmentation tool, FAST. SPM’s DARTEL tool was used for subject registration and FreeSurfer allowed the creation of individual and an average cortical surface. The lesion masks created after the manual segmentation task followed a similar processing route to allow their overlay on the respective brain volumes and, posteriorly, surfaces, and the possibility of individual and group analyses. Results showed that the currently available MRI image processing tools present overall good performance and reliability in the processing of higher resolution data of multiple sclerosis patients. Still, the quality of the outcomes can be optimized by including additional steps or changes to the original software configurations. Modifying SPM’s smoothness and regularization parameters for the estimation of bias minimized its effect in the data, allowing a better differentiation between grey matter and white matter. Removing the skull whilst keeping the coregistration to rigid body transformations allowed the use of several contrasts in the lesion detection task without interfering with the lesions’ morphology and topography. Brain segmentation using CAT showed more stability across the dataset, improving the quality of the subsequent subject registration and consequently of the average brain created. The success of the pipeline led to the possibility of overlaying the manually segmented lesions on the individual and group surfaces where it was found that the majority of lesions occurred on the right hemisphere and that lesion overlaps were more common in cortical sulci. Despite the results obtained, further research is needed to understand the performance of other software packages in the processing of higher resolution MRI data and how to fully exploit these tools in the study of clinical data at 7 T

Ultrahigh field MRI in clinical neuroimmunology: a potential contribution to improved diagnostics and personalised disease management

Conventional magnetic resonance imaging (MRI) at 1.5 Tesla (T) is limited by modest spatial resolution and signal-to-noise ratio (SNR), impeding the identification and classification of inflammatory central nervous system changes in current clinical practice. Gaining from enhanced susceptibility effects and improved SNR, ultrahigh field MRI at 7 T depicts inflammatory brain lesions in great detail. This review summarises recent reports on 7 T MRI in neuroinflammatory diseases and addresses the question as to whether ultrahigh field MRI may eventually improve clinical decision-making and personalised disease management

Neuroimaging of structural pathology and connectomics in traumatic brain injury: Toward personalized outcome prediction.

Recent contributions to the body of knowledge on traumatic brain injury (TBI) favor the view that multimodal neuroimaging using structural and functional magnetic resonance imaging (MRI and fMRI, respectively) as well as diffusion tensor imaging (DTI) has excellent potential to identify novel biomarkers and predictors of TBI outcome. This is particularly the case when such methods are appropriately combined with volumetric/morphometric analysis of brain structures and with the exploration of TBI-related changes in brain network properties at the level of the connectome. In this context, our present review summarizes recent developments on the roles of these two techniques in the search for novel structural neuroimaging biomarkers that have TBI outcome prognostication value. The themes being explored cover notable trends in this area of research, including (1) the role of advanced MRI processing methods in the analysis of structural pathology, (2) the use of brain connectomics and network analysis to identify outcome biomarkers, and (3) the application of multivariate statistics to predict outcome using neuroimaging metrics. The goal of the review is to draw the community's attention to these recent advances on TBI outcome prediction methods and to encourage the development of new methodologies whereby structural neuroimaging can be used to identify biomarkers of TBI outcome

Quantitative Susceptibility Imaging of Tissue Microstructure Using Ultra-High Field MRI

This thesis has used ultra-high field (UHF) magnetic resonance imaging (MRI) to investigate the fundamental relationships between tissue microstructure and such susceptibility-based contrast parameters as the apparent transverse relaxation rate (R2*), the local Larmor frequency shift (LFS) and quantitative volume magnetic susceptibility (QS). The interaction of magnetic fields with biological tissues results in shifts in the LFS which can be used to distinguish underlying cellular architecture. The LFS is also linked to the relaxation properties of tissues in a gradient echo MRI sequence. Equally relevant, histological analysis has identified iron and myelin as two major sources of the LFS. As a result, computation of LFS and the associated volume magnetic susceptibility from MRI phase data may serve as a significant method for in vivo monitoring of changes in iron and myelin associated with normal, healthy aging, as well as neurological disease processes. In this research, the cellular level underpinnings of the R2* and LFS signals were examined in a model rat brain system using 9.4 T MRI. The study was carried out using biophysical modeling and correlation with quantitative histology. For the first time, multiple biophysical modeling schemes were compared in both gray and white matter of excised rat brain tissue. Suprisingly, R2* dependence on tissue orientation has not been fully understood. Accordingly, scaling relations were derived for calculating the reversible, mesoscopic magnetic field component, R2\u27, of the apparent transverse relaxation rate from the orientation dependence in gray and white matter. Our results demonstrate that the orientation dependence of R2* and LFS in both white and cortical gray matter has a sinusoidal dependence on tissue orientation and a linear dependence on the volume fraction of myelin in the tissue. A susceptibility processing pipeline was also developed and applied to the calculation of phase-combined LFS and QS maps. The processing pipeline was subsequently used to monitor myelin and iron changes in multiple sclerosis (MS) patients compared to healthy, age and gender-matched controls. With the use of QS and R2* mapping, evidence of statistically significant increases in iron deposition in sub-cortical gray matter, as well as myelin degeneration along the white matter skeleton, were identified in MS patients. The magnetic susceptibility-based MRI methods were then employed as potential clinical biomarkers for disease severity monitoring of MS. It was demonstrated that the combined use of R2* and QS, obtained from multi-echo gradient echo MRI, could serve as an improved metric for monitoring both gray and white matter changes in early MS

Quantitative MRI correlates of hippocampal and neocortical pathology in intractable temporal lobe epilepsy

Intractable or drug-resistant epilepsy occurs in over 30% of epilepsy patients, with many of these patients undergoing surgical excision of the affected brain region to achieve seizure control. Advances in MRI have the potential to improve surgical treatment of epilepsy through improved identification and delineation of lesions. However, validation is currently needed to investigate histopathological correlates of these new imaging techniques. The purpose of this work is to investigate histopathological correlates of quantitative relaxometry and DTI from hippocampal and neocortical specimens of intractable TLE patients. To achieve this goal I developed and evaluated a pipeline for histology to in-vivo MRI image registration, which finds dense spatial correspondence between both modalities. This protocol was divided in two steps whereby sparsely sectioned histology from temporal lobe specimens was first registered to the intermediate ex-vivo MRI which is then registered to the in-vivo MRI, completing a pipeline for histology to in-vivo MRI registration. When correlating relaxometry and DTI with neuronal density and morphology in the temporal lobe neocortex, I found T1 to be a predictor of neuronal density in the neocortical GM and demonstrated that employing multi-parametric MRI (combining T1 and FA together) provided a significantly better fit than each parameter alone in predicting density of neurons. This work was the first to relate in-vivo T1 and FA values to the proportion of neurons in GM. When investigating these quantitative multimodal parameters with histological features within the hippocampal subfields, I demonstrated that MD correlates with neuronal density and size, and can act as a marker for neuron integrity within the hippocampus. More importantly, this work was the first to highlight the potential of subfield relaxometry and diffusion parameters (mainly T2 and MD) as well as volumetry in predicting the extent of cell loss per subfield pre-operatively, with a precision so far unachievable. These results suggest that high-resolution quantitative MRI sequences could impact clinical practice for pre-operative evaluation and prediction of surgical outcomes of intractable epilepsy

International Veterinary Epilepsy Task Force recommendations for a veterinary epilepsy-specific MRI protocol

Epilepsy is one of the most common chronic neurological diseases in veterinary practice. Magnetic resonance imaging (MRI) is regarded as an important diagnostic test to reach the diagnosis of idiopathic epilepsy. However, given that the diagnosis requires the exclusion of other differentials for seizures, the parameters for MRI examination should allow the detection of subtle lesions which may not be obvious with existing techniques. In addition, there are several differentials for idiopathic epilepsy in humans, for example some focal cortical dysplasias, which may only apparent with special sequences, imaging planes and/or particular techniques used in performing the MRI scan. As a result, there is a need to standardize MRI examination in veterinary patients with techniques that reliably diagnose subtle lesions, identify post-seizure changes, and which will allow for future identification of underlying causes of seizures not yet apparent in the veterinary literature. There is a need for a standardized veterinary epilepsy-specific MRI protocol which will facilitate more detailed examination of areas susceptible to generating and perpetuating seizures, is cost efficient, simple to perform and can be adapted for both low and high field scanners. Standardisation of imaging will improve clinical communication and uniformity of case definition between research studies. A 6–7 sequence epilepsy-specific MRI protocol for veterinary patients is proposed and further advanced MR and functional imaging is reviewed

Clinical applications of ultra-high field magnetic resonance imaging in multiple sclerosis

Introduction: Magnetic resonance imaging (MRI) is of paramount importance for the early diagnosis of multiple sclerosis (MS) and MRI findings are part of the MS diagnostic criteria. There is a growing interest in the use of ultra-high-field strength 127 Tesla- (7T) MRI to investigate, in vivo, the pathological substrate of the disease. Areas covered: An overview of 7T MRI applications in MS focusing on increased sensitivity for lesion detection, specificity of the central vein sign and better understanding of MS pathophysiology. Implications for disease diagnosis, monitoring and treatment planning are discussed. Expert commentary: 7T MRI provides increased signal-to-noise and contrast-to-noise-ratio that allow higher spatial resolution and better detection of anatomical and pathological features. The high spatial resolution reachable at 7T has been a game changer for neuroimaging applications not only in MS but also in epilepsy, brain tumors, dementia, and neuro-psychiatric disorders. Furthermore, the first 7T device has recently been cleared for clinical use by the food and drug administration